Tori Spelling and Stella McDermott, Arcutis Partner to Raise Awareness About Inflammatory Skin Conditions October 31, 2025
AD Pipeline Update: Concerto Biosciences’ ENS-002 Shows Safety and Efficacy in Phase 1b Trial October 28, 2025
New Phase 3b Data Reinforce the Safety and Efficacy Profile of Ruxolitinib Cream in Moderate AD October 27, 2025